Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tapentadol (as tapentadol hydrochloride) 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tapentadol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tapentadol (as tapentadol hydrochloride) 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 75 mg oral tablet |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 4 mg/mL oral solution |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tapentadol (as tapentadol hydrochloride) 20 mg/mL oral solution |
Has precise active ingredient |
True |
Tapentadol hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |